Patient-derived organoids (PDOs): a novel preclinical platform to overcome challenges in cancer immunotherapy
Cancer immunotherapy has revolutionized oncology but faces significant challenges including low response rates and lack of effective preclinical models. This review elucidates how patient-derived organoids (PDOs) are emerging as a transformative platform to address these hurdles. We detail sophistic...
Zapisane w:
| Główni autorzy: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Frontiers Media S.A.
2026-02-01
|
| Seria: | Frontiers in Cell and Developmental Biology |
| Hasła przedmiotowe: | |
| Dostęp online: | https://www.frontiersin.org/articles/10.3389/fcell.2026.1757516/full |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|